Skip to main content
Clinical Trials/NCT00447291
NCT00447291TerminatedPhase 3

Evaluation of the Safety and Efficacy of Omega-3 Fish Oil Dietary Supplementation in Biometric Measurement, Lipid Profile, Serum Markers for Inflammation, and Insulin Resistance in Overweight Children and Adolescents

Children's Heart Center2 sites in 1 country60 target enrollmentStarted: December 1, 2006Last updated:
Conditions
Drugs

Trial Snapshot

Phase
Phase 3
Status
Terminated
Sponsor
Enrollment
60
Locations
2
Primary Endpoint
To compare effects between Omega 3 fish oil and placebo

Study Overview

Brief Summary

Children with an excess in body weight, increase the risk of obesity-related co-morbidities and cardiovascular diseases. Childhood obesity may be due to diets laden with fat and lack of physical activity. Omega-3 fish oil is a supplementation that may promote a greater reduction of pro-inflammatory mediators; combined with exercise and nutritional regimens it may also help improve glycemic, lipid markers, and body composition in overweight children and adolescents.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Supportive Care
Masking
Triple (Participant, Care Provider, Investigator)

Eligibility Criteria

Ages
8 Years to 18 Years (Child, Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Between 8-18 years old
  • BMI ≥95th percentile
  • Patient & parent/guardian consent to participate
  • Attendance of Risk Factor Reduction lifestyle modification program

Exclusion Criteria

  • Major surgical Procedure within 1 year
  • Significant cardiovascular disease or other morbidity that preclude patients from following dietary regimen or exercising.
  • Mentally Challenged
  • Currently taking fish oil supplements, unless 1 month wash-out period is achieved.

Outcomes

Primary Outcomes

To compare effects between Omega 3 fish oil and placebo

Time Frame: 3 months

To compare the effect of Omega 3 fish oil dietary supplementation versus placebo on biometric measurement, lipid profile, serum markers for inflammation and insulin resistance in overweight children and adolescents undergoing treatment with a low-glycemic load diet and exercise.

Secondary Outcomes

  • To compare effects between Omega 3 fish oil and placebo(3 months)

Investigators

Sponsor
Children's Heart Center
Sponsor Class
Industry

Study Sites (2)

Loading locations...

Similar Trials